Page last updated: 2024-09-02

zinc coproporphyrin iii and Lymphoma

zinc coproporphyrin iii has been researched along with Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz-de Bretagne, I; Choquet, S; Gyan, E; Hoang-Xuan, K; Houillier, C; Hulot, JS; Le Gouge, A; Le Guellec, C; Lissandre, S; Zahr, N	1

Trials

1 trial(s) available for zinc coproporphyrin iii and Lymphoma

Article	Year
Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance. British journal of clinical pharmacology, 2014, Volume: 78, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Coproporphyrins; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Models, Biological; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Young Adult	2014

Article

Year

Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

British journal of clinical pharmacology, 2014, Volume: 78, Issue:2

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Coproporphyrins; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Models, Biological; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Young Adult

2014